Trademark: 87655611
Status Date
Monday, May 31, 2021
Filing Date
Monday, October 23, 2017
Published for Opposition
Tuesday, February 27, 2018
Abandoned Date
Monday, May 31, 2021
5 Human pharmaceutical preparations for treatment of inflammatory diseases, oncological, cardiovascular, central nervous system and auto-immune diseases
Jun 1, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
May 31, 2021
Abandonment - No Use Statement Filed
Sep 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 23, 2020
Extension 5 Granted
Sep 18, 2020
Extension 5 Filed
Sep 18, 2020
Teas Extension Received
Apr 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2020
Extension 4 Granted
Apr 2, 2020
Extension 4 Filed
Apr 2, 2020
Teas Extension Received
Oct 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2019
Extension 3 Granted
Oct 21, 2019
Extension 3 Filed
Oct 21, 2019
Teas Extension Received
Apr 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2019
Extension 2 Granted
Apr 12, 2019
Extension 2 Filed
Apr 12, 2019
Teas Extension Received
Jan 30, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 29, 2019
Extension 1 Granted
Oct 24, 2018
Extension 1 Filed
Jan 25, 2019
Case Assigned To Intent To Use Paralegal
Nov 16, 2018
Notice Of Revival - E-Mailed
Nov 16, 2018
Extension Received With Teas Petition
Nov 16, 2018
Petition To Revive-Granted
Nov 16, 2018
Teas Petition To Revive Received
Apr 24, 2018
Noa E-Mailed - Sou Required From Applicant
Feb 27, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2018
Published For Opposition
Feb 7, 2018
Notification Of Notice Of Publication E-Mailed
Jan 24, 2018
Approved For Pub - Principal Register
Jan 23, 2018
Assigned To Examiner
Nov 1, 2017
New Application Office Supplied Data Entered In Tram
Oct 26, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
